Literature DB >> 17589934

Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.

Damien Sene1, Valerie Touitou, Bahram Bodaghi, David Saadoun, Gabriel Perlemuter, Nathalie Cassoux, Jean-Charles Piette, Phuc-Le Hoang, Patrice Cacoub.   

Abstract

We report a panel of severe inflammatory and vascular intraocular disorders occurring during interferon-alpha (IFN-alpha) treatment in eight hepatitis C virus (HCV)-infected patients. These events include three cases of Vogt-Koyanagi-Harada like (VKH) disease (an association of panuveitis, retinal detachment, ear and meningeal detachment and skin and hair changes), two cases of central retinal vein occlusion, one case of central retinal artery occlusion, one case of severe hypertensive retinopathy and one case of bilateral ischemic optic neuropathy with severe visual impairment. Rare as they are, such severe ophthalmological complications require a close follow-up of HCV-infected patients under IFN-alpha treatment with ophthalmological monitoring if any ocular manifestation occurs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589934      PMCID: PMC4172625          DOI: 10.3748/wjg.v13.i22.3137

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  [Hepatitis-C-positive mixed essential cryoglobulinemia, autoimmune hemolytic anemia, and immune thrombocytopenic purpura].

Authors:  P Ríos-Rull; M Rubio; E Ojeda; F Hernández Navarro
Journal:  Sangre (Barc)       Date:  1994-06

2.  Clinical characteristics of hepatitis C virus-associated retinopathy.

Authors:  T Abe; A Nakajima; N Satoh; T Koizumi; S Sakuragi; T Ono; M Komatsu; O Masamune
Journal:  Jpn J Ophthalmol       Date:  1995       Impact factor: 2.447

3.  Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.

Authors:  Konstantinos Papastathopoulos; Evridiki Bouzas; George Naoum; Ioannis Vergados; Sotirios Tsiodras
Journal:  J Infect       Date:  2005-06-13       Impact factor: 6.072

Review 4.  Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature.

Authors:  A Nadir; A Amin; N Chalisa; D H van Thiel
Journal:  J Viral Hepat       Date:  2000-11       Impact factor: 3.728

5.  Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C.

Authors:  Valérie Touitou; Bahram Bodaghi; Nathalie Cassoux; Thi Ha Chau Tran; Narsing A Rao; Patrice Cacoub; Phuc LeHoang
Journal:  Am J Ophthalmol       Date:  2005-11       Impact factor: 5.258

6.  Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin.

Authors:  Claire Farel; Daniel L Suzman; Mary McLaughlin; Colleen Campbell; Chad Koratich; Henry Masur; Julia A Metcalf; Michael R Robinson; Michael A Polis; Shyam Kottilil
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

7.  Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.

Authors:  Gabriel Perlemuter; Patrice Cacoub; Abdallah Sbaï; Pierre Hausfater; Vincent Thibault; Thi Huong Du Le; Bertrand Wechsler; Catherine Buffet; Jean Charles Piette
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

Review 8.  Ocular manifestations of hepatitis C virus infection.

Authors:  Michael E Zegans; William Anninger; Christopher Chapman; Stuart R Gordon
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

9.  Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.

Authors:  D L Sylvestre; A R Disston; D P Bui
Journal:  J Viral Hepat       Date:  2003-11       Impact factor: 3.728

10.  Interferon-associated retinopathy.

Authors:  D R Guyer; J Tiedeman; L A Yannuzzi; J S Slakter; D Parke; J Kelley; R A Tang; M Marmor; G Abrams; J W Miller
Journal:  Arch Ophthalmol       Date:  1993-03
View more
  17 in total

1.  [Acute loss of vision during therapy of chronic hepatitis C].

Authors:  J P Salgado; R Khoramnia; M M Maier; C P Lohmann; C Winkler von Mohrenfels
Journal:  Ophthalmologe       Date:  2011-06       Impact factor: 1.059

2.  Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.

Authors:  Abdulrahman M Al-Muammar; Tariq M Al-Mudhaiyan; Mohammed Al Otaibi; Ayman Abdo; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2010-02-23       Impact factor: 2.031

Review 3.  Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Authors:  Roderick O'Day; Mark C Gillies; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

4.  Pegylated interferon alpha-associated optic neuropathy.

Authors:  Kathleen T Berg; Bruce Nelson; Andrew R Harrison; Linda K McLoon; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

5.  Ophthalmological side effects of interferon therapy of chronic hepatitis C.

Authors:  Eman Medhat; Gamal Esmat; Eman Hamza; Amr Abdel Aziz; Waleed Fouad Fathalah; Samar Kamal Darweesh; Zeinab Zakaria; Sameh Mostafa
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

Review 6.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

7.  Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon.

Authors:  Michael R Narkewicz; Philip Rosenthal; Kathleen B Schwarz; Arlene Drack; Todd Margolis; Michael X Repka
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-08       Impact factor: 2.839

8.  Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.

Authors:  Jian-Qing Yang; Guang-Dong Pan; Guang-Ping Chu; Zhen Liu; Qiang Liu; Yi Xiao; Lin Yuan
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

9.  Bilateral Ischemic Optic Neuropathy Developed under Interferon Therapy.

Authors:  Fatih Selcukbiricik; Deniz Tural; Tuba Elif Senel; Ahmet Sarıca; Ozlem Soyluk; Suheyla Serdengecti
Journal:  Case Rep Ophthalmol Med       Date:  2012-10-18

10.  Probable Vogt-Koyanagi-Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier.

Authors:  Nikki Y Far; David T L Liu
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.